TCL Archive In Brief: David Nathan receives Lifetime Impact Award from Boston Children’s Hospital November 7, 2014
TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005
TCL Archive News Analysis by Keith Baggerly: Duke Trials Went On Despite FDA Statements January 27, 2012
TCL Archive Former NCAB chairman, President’s Cancer Panel member Paul Calabresi dead at 73. October 31, 2003
TCL Archive NIH Panel finalizes Consensus Statement; Two Panelists Join In Minority Opinion March 28, 1997
